Association of HLA-E polymorphism with the outcome of hematopoietic stem-cell transplantation with unrelated donors

Transplantation

Volumn 88, Issue 10, 2009, Pages 1227-1228

  Ludajic, Katarina ^a   Rosenmayr, Agathe ^a   Faé, Ingrid ^a   Fischer, Gottfried F ^a   Balavarca, Yesilda ^b   Bickeböller, Heike ^b   Kalhs, Peter ^a   Greinix, Hildegard T ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; DNA; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; HLA DR5 ANTIGEN; HLA E ANTIGEN; MINOR HISTOCOMPATIBILITY ANTIGEN; VIRUS ANTIGEN;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ALLELE; BONE MARROW DEPRESSION; CELL SURFACE; CHRONIC GRAFT VERSUS HOST DISEASE; DISEASE MARKER; DISEASE PREDISPOSITION; DNA POLYMORPHISM; DNA SEQUENCE; DONOR SELECTION; FEMALE; FOLLOW UP; GENE EXPRESSION; GENE LOCUS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEREDITY; HUMAN; IMMUNOLOGY; INCIDENCE; LETTER; LYMPHOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NERVE FIBER; PEDIATRICS; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; RELAPSE; RISK ASSESSMENT; SURVIVAL; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

ACUTE DISEASE; CHRONIC DISEASE; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; LIVING DONORS; PATIENT SELECTION; POLYMORPHISM, GENETIC; REGRESSION ANALYSIS; TISSUE DONORS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 73849094764     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181bbb8fe     Document Type: Letter

References (9)

1. Lee N, Llano M, Carretero M, et al. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci USA 1998; 95: 5199.
2. Strong RK, Holmes MA, Li P, et al. HLA-E allelic variants. Correlating differential expression, peptide affinities, crystal structures, and thermal stabilities. J Biol Chem 2003; 278: 5082.
3. Greinix HT, Fae I, Schneider B, et al. Impact of HLA class I high-resolution mismatches on chronic graft-versus-host disease and survival of patients given hematopoietic stem cell grafts from unrelated donors. Bone Marrow Transplant 2005; 35: 57.
4. Ludajic K, Balavarca Y, Bickeboller H, et al. Impact of HLA-DPB1 allelic and single amino acid mismatches on HSCT. Br J Haematol 2008; 142: 436.
5. Tamouza R, Rocha V, Busson M, et al. Association of HLA-E polymorphism with severe bacterial infection and early transplant-related mortality in matched unrelated bone marrow transplantation. Transplantation 2005; 80: 140.
6. Gluckman E, Wagner JE. Hematopoietic stem cell transplantationinchildhood inherited bone marrow failure syndrome. Bone Marrow Transplant 2008; 41: 127.
7. Bensinger WI, Martin PJ, Storer B, et al. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med 2001; 344: 175.
8. Ulbrecht M, Couturier A, Martinozzi S, et al. Cell surface expression of HLA-E: Interaction with human beta2-microglobulin and allelic differences. Eur J Immunol 1999; 29: 537.
9. Tamouza R, Busson M, Rocha V, et al. Ho-mozygous status for HLA-E*0103 confers protection from acute graft-versus-host disease and transplant-related mortality in HLA-matched sibling hematopoietic stem cell transplantation. Transplantation 2006; 82: 1436.